Tag: biosimilars
Biosimilar Safety Monitoring: How Adverse Event Surveillance Works
Harrison Greywell Feb, 5 2026 8Biosimilars require specialized safety monitoring due to their complex nature. Learn how regulatory agencies track adverse events, the challenges in reporting, and why this process is crucial for patient safety.
More Detail